Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TITAN: Adenosine for Takotsubo Syndrome
NCT02867878Phase 2Terminated
- Sponsor
- Azienda Ospedaliero-Universitaria di Ferrara
- Start
- Aug 2016
- Primary completion
- Oct 2018
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of adenosine in takotsubo syndrome (TTS), sponsored by Azienda Ospedaliero-Universitaria di Ferrara. Started Aug 2016; status: terminated.
02
Drugs
adenosine
03
Conditions
takotsubo syndrome (TTS)
Beyond the preview
Go deeper on NCT02867878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02867878.